GILD News Alert Gilead Sciences (GILD) 101.21 01/12/2015 16:

New Post Public Reply Private Reply Replies (0) Message Board

Jan 12, 2015 at 5:16 PM

Gilead Sciences (GILD) 101.21 $GILD

Gilead Sciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 13
Business Wire - 15 mins ago
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco.
JPM: 58.83 (-0.51), GILD: 101.21 (-1.00)

Abbvie Retreats On Gilead, Anthem Deal. Buying Opportunity?
Shock Exchange - at Seeking Alpha - 2 hrs 28 mins ago

GILD: 101.21 (-1.00), ABBV: 65.76 (-0.02)

Prime Therapeutics Breaks from Competition, Strikes Deals to Prefer both Harvoni, Viekira Hepatitis C Drugs
PR Newswire - Mon Jan 12, 1:00PM CST
People with Hepatitis C who are served by pharmacy benefit manager Prime Therapeutics LLC (Prime) will now have greater support for the treatment recommended by their physician. This is a result of new agreements between Prime and pharmaceutical companies Gilead Sciences and AbbVie. Beginning immediately, the agreements place both Gilead's Harvoni® and AbbVie's Viekira Pak® on Prime's preferred drug list (formulary), meaning members can more easily get the medicine they need to feel better and live well.
GILD: 101.21 (-1.00)

Midday Glance: Biotechnology companies
AP - Mon Jan 12, 12:23PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 101.21 (-1.00), AMGN: 156.22 (+0.49), CELG: 117.00 (+3.33)

Earnings Season Kicks Off Tonight: Here's What To Expect
Leigh Drogen - at Seeking Alpha - Mon Jan 12, 11:58AM CST
Earnings season unofficially kicks off today after the closing bell when Alcoa (NYSE: AA ) releases results for the fourth quarter. Current estimates paint a picture of two earnings seasons in a couple of regards. Yes, profit growth is expected to...
FDX: 172.57 (-0.09), NKE: 95.86 (-0.13), C: 50.38 (-0.40), BAC: 16.68 (-0.30), WFC: 52.05 (-0.63), UPS: 109.64 (+0.04), T: 33.49 (+0.09), AA: 16.17 (+0.06), GS: 185.07 (-2.28), JPM: 58.83 (-0.51), GILD: 101.21 (-1.00), MCD: 93.01 (-0.20), VZ: 47.08 (+0.32), AAPL: 109.25 (-2.76), YUM: 72.91 (-0.55)

Value Investing Strategy For Biotech
Henry Wolfe - at Seeking Alpha - Mon Jan 12, 11:57AM CST

CARA: 10.99 (+0.04), BLCM: 31.33 (-0.42), GILD: 101.21 (-1.00), KITE: 82.35 (+3.21), CLDX: 19.03 (-0.08), CALA: 22.86 (-0.78), AGIO: 131.55 (+3.43)

I'm Expecting Some Very Positive News Flow From Gilead
Brian Nelson - at Seeking Alpha - Mon Jan 12, 10:55AM CST

JNJ: 104.58 (-0.36), ABT: 45.58 (+0.38), VRTX: 118.31 (-3.90), ESRX: 83.08 (-1.82), GILD: 101.21 (-1.00), ACHN: 14.64 (+0.08), MRK: 62.30 (-0.26), CVS: 97.20 (-0.72), ABBV: 65.76 (-0.02), ENTA: 49.41 (-0.70)

Gilead Strikes Hep-C Deal With Anthem. Stock Remains Strong Buy
Shock Exchange - at Seeking Alpha - Mon Jan 12, 10:31AM CST

ANTM: 128.83 (-0.97), GILD: 101.21 (-1.00), ABBV: 65.76 (-0.02)

Earnings Season Kicks Off Tonight: Here’s What to Expect
ESTMZ - Mon Jan 12, 10:12AM CST
Earnings season unofficially kicks off today after the closing bell when Alcoa releases results for the fourth quarter. Current estimates paint a picture of two earnings seasons in a couple of regards. Yes, profit growth is expected to continue...
FDX: 172.57 (-0.09), T: 33.49 (+0.09), AA: 16.17 (+0.06), GS: 185.07 (-2.28), JPM: 58.83 (-0.51), GILD: 101.21 (-1.00), C: 50.38 (-0.40), WFC: 52.05 (-0.63), BAC: 16.68 (-0.30), VZ: 47.08 (+0.32), UPS: 109.64 (+0.04)

Early Glance: Biotechnology companies
AP - Mon Jan 12, 9:45AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 101.21 (-1.00), AMGN: 156.22 (+0.49), CELG: 117.00 (+3.33)

Today's Market: Pharma And Biotech M&A Start 2015 With A Bang
Matthew Smith - at Seeking Alpha - Mon Jan 12, 9:13AM CST

ABC: 90.93 (-2.07), FMI: 46.74 (+22.81), MWIV: 190.00 (+14.35), GILD: 101.21 (-1.00), SHPG: 209.10 (-8.39), TKMR: 24.68 (+8.98), NPSP: 45.35 (+3.44), ABBV: 65.76 (-0.02)

Tekmira teams up with OnCore to focus on hepatitis B cure
By The Associated Press - AP - Mon Jan 12, 8:52AM CST
Shares of Tekmira Pharmaceuticals soared Monday after the Canadian drugmaker said it would buy privately held OnCore Biopharma to form a team focused on developing a hepatitis B cure.
GILD: 101.21 (-1.00), TKMR: 24.68 (+8.98), TKM.TO: 29.38 (+10.55)

My Predictions For 2015 - Final Chapter
Bret Jensen - at Seeking Alpha - Mon Jan 12, 8:07AM CST

DVAX: 18.58 (+0.87), AGEN: 6.17 (+0.88), GILD: 101.21 (-1.00), GBX: 50.61 (-2.15), AAPL: 109.25 (-2.76)

1 Big Loser in the Slugfest Between AbbVie and Gilead Sciences
Keith Speights, The Motley Fool - Motley Fool - Mon Jan 12, 8:03AM CST
Source: Wikimedia Commons An epic fight is under way in the world of hepatitis C. We've seen a couple of punches thrown just over the last few days. The latest occurred on Thursday with Anthem 's selection of Gilead Sciences ' Harvoni as a...
ANTM: 128.83 (-0.97), ESRX: 83.08 (-1.82), CTRX: 49.24 (-0.49), JPM: 58.83 (-0.51), GILD: 101.21 (-1.00), CVS: 97.20 (-0.72), ABBV: 65.76 (-0.02), MS: 36.37 (-0.51)

Which Big Biotech Will Soar in 2015?
Motley Fool Staff - Motley Fool - Mon Jan 12, 7:59AM CST
In a bid to help investors identify the biotech companies that could be top stocks this year, we asked three top Motley Fool contributors to tell us which biotech stocks they think could head significantly higher in 2015. Read on to learn which...
BIIB: 347.84 (+5.50), ESRX: 83.08 (-1.82), GILD: 101.21 (-1.00), ABBV: 65.76 (-0.02), CELG: 117.00 (+3.33)

Is Celgene Corporation a Takeover Target in 2015?
George Budwell, The Motley Fool - Motley Fool - Mon Jan 12, 6:30AM CST
Source: Celgene. The pharmaceutical industry underwent a major consolidation last year, driven by the loss of former top-selling drugs to the patent cliff, huge cash positions built up over the preceding decade, and an innovation boom that has made...
BLUE: 101.95 (-1.68), GILD: 101.21 (-1.00), PFE: 32.77 (+0.12), GSK: 42.93 (+0.13), BMY: 62.18 (+1.86), CELG: 117.00 (+3.33)

Should AbbVie Inc. Or Gilead Sciences Buy These Tiny Biotech Stocks?
Todd Campbell, The Motley Fool - Motley Fool - Sun Jan 11, 12:04PM CST
Recently approved new drugs from AbbVie and Gilead Sciences means that the two biotech titans are locked in a heated battle for hepatitis C market share, but these companies may be better served shifting their attention away from this tussle...
ESRX: 83.08 (-1.82), ISIS: 73.34 (+1.08), ALNY: 103.78 (+2.48), GILD: 101.21 (-1.00), ACHN: 14.64 (+0.08), RGLS: 18.90 (-0.43), ABBV: 65.76 (-0.02)

Better Healthcare Buy: Big or Little Biotechs
Motley Fool Staff - Motley Fool - Sun Jan 11, 11:32AM CST
Source: Flickr user Chris Potter Biotechnology stocks were among the market's top performers in 2014, but biotech stocks were also among the market's riskiest plays. For risk tolerant investors, biotech's pop-and-drop nature may be enticing, but...
BIIB: 347.84 (+5.50), GILD: 101.21 (-1.00)

5 Predictions for Biotechnology Stocks in 2015
Todd Campbell, The Motley Fool - Motley Fool - Sun Jan 11, 10:02AM CST
Biotechnology was one of the market's shining stars in 2014. The Nasdaq Biotechnology Index ETF returned an impressive 33% last year, significantly outpacing the performance of the S&P 500. Of course, no one can know if biotechnology stocks will...
BLUE: 101.95 (-1.68), ACT: 272.28 (+3.60), AMGN: 156.22 (+0.49), RGLS: 18.90 (-0.43), EPZM: 17.49 (+0.01), ALKS: 68.61 (+3.47), HSP: 61.55 (-0.09), CELG: 117.00 (+3.33), JNJ: 104.58 (-0.36), ESRX: 83.08 (-1.82), GILD: 101.21 (-1.00), GWPH: 78.73 (+0.20), ACHN: 14.64 (+0.08), MRK: 62.30 (-0.26), ABBV: 65.76 (-0.02), AGIO: 131.55 (+3.43), XLRN: 40.89 (-0.25), NVS: 95.48 (-0.64)

3 Ways Gilead Sciences, Inc. Could Still Be in Big Trouble
Sean Williams, The Motley Fool - Motley Fool - Sun Jan 11, 8:02AM CST
Arguably no biotech stock thrilled investors in 2014 more than Gilead Sciences . Gilead finished the year up 26%, about double the performance of the broad-market indexes, and the approval and exceptional launch of hepatitis C drugs Sovaldi and...
VRTX: 118.31 (-3.90), ESRX: 83.08 (-1.82), GILD: 101.21 (-1.00), MRK: 62.30 (-0.26), AZN: 70.79 (+1.35), ABBV: 65.76 (-0.02)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webinar Highlights Workforce Skills and AI Tools

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

1M+ California Homes Face Extreme Wildfire Risk Revealed

Wildfire Risk in California: A Growing Alarm If there's one thing that's become a bitter truth over the years, it's that California and wildfires are inseparably linked, like mayo on a greasy diner BLT—except way worse for the gut. The latest round of data from Guidewire HazardHub is practically sounding the alarm bells louder than ever. Over a million homes in...

Drunk Angel Celebrates First Year in Crystal Jewelry

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

Verdafero Gains Ground in Sustainable Hospitality

Verdafero's Latest Milestone: A Broader Environmental Reach It’s a day like today that makes you pause and realize that businesses in the hospitality space aren’t just about fluff and fancy lobbies anymore. They've got a new wave of responsibilities, especially with the globe pretty much on fire, literally and figuratively. Verdafero, a name not new to function and...

Big Wins at Americas Cardroom's $15M Venom Series

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Muscle Car Fever Revs Up in New Global TV Series

Chasing the Dream on Wheels Amid the buzz of New York, there's a roar building up that's hard to ignore. It's a sound that echoes through time, capturing the imagination of petrol heads everywhere—those legendary American muscle cars are back in the limelight. I mean, who hasn't dreamt of launching down a highway in a '69 Ford Mustang? 'The Hunt for Rolling Treasure' is...

ASCEND® Cladding Unveils New Profiles & Texture Variety

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

Nashville Benefit Concert Supports Animal Rescue Mission

Country Tunes and Compassion Unite for Rescue Efforts There's something electric about a community banding together, especially when it's through the warmth of country music and the noble mission of animal rescue. Animal Rescue Corps (ARC), meeting ground for art and heart, is turning the Nashville Palace into a sanctuary not just for music, but for hope. They've got...

Spot the Signs: Early Gum Disease Insights from Experts

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Mandeville Pests: Health Dangers Lurking at Home

Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...